445 related articles for article (PubMed ID: 19720788)
1. Glucagon-like peptide-1 agonists protect pancreatic beta-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB.
Cunha DA; Ladrière L; Ortis F; Igoillo-Esteve M; Gurzov EN; Lupi R; Marchetti P; Eizirik DL; Cnop M
Diabetes; 2009 Dec; 58(12):2851-62. PubMed ID: 19720788
[TBL] [Abstract][Full Text] [Related]
2. JunB protects β-cells from lipotoxicity via the XBP1-AKT pathway.
Cunha DA; Gurzov EN; Naamane N; Ortis F; Cardozo AK; Bugliani M; Marchetti P; Eizirik DL; Cnop M
Cell Death Differ; 2014 Aug; 21(8):1313-24. PubMed ID: 24786832
[TBL] [Abstract][Full Text] [Related]
3. Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a.
Younce CW; Burmeister MA; Ayala JE
Am J Physiol Cell Physiol; 2013 Mar; 304(6):C508-18. PubMed ID: 23302777
[TBL] [Abstract][Full Text] [Related]
4. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
[TBL] [Abstract][Full Text] [Related]
5. Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line.
Wei Q; Sun YQ; Zhang J
Peptides; 2012 Sep; 37(1):18-24. PubMed ID: 22776329
[TBL] [Abstract][Full Text] [Related]
6. Protection of pancreatic beta-cells by exendin-4 may involve the reduction of endoplasmic reticulum stress; in vivo and in vitro studies.
Tsunekawa S; Yamamoto N; Tsukamoto K; Itoh Y; Kaneko Y; Kimura T; Ariyoshi Y; Miura Y; Oiso Y; Niki I
J Endocrinol; 2007 Apr; 193(1):65-74. PubMed ID: 17400804
[TBL] [Abstract][Full Text] [Related]
7. GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress.
Yusta B; Baggio LL; Estall JL; Koehler JA; Holland DP; Li H; Pipeleers D; Ling Z; Drucker DJ
Cell Metab; 2006 Nov; 4(5):391-406. PubMed ID: 17084712
[TBL] [Abstract][Full Text] [Related]
8. Differential protective effects of exenatide, an agonist of GLP-1 receptor and Piragliatin, a glucokinase activator in beta cell response to streptozotocin-induced and endoplasmic reticulum stresses.
Kim MK; Cho JH; Lee JJ; Cheong YH; Son MH; Lee KJ
PLoS One; 2013; 8(9):e73340. PubMed ID: 24069189
[TBL] [Abstract][Full Text] [Related]
9. Exendin-4 protects against sulfonylurea-induced β-cell apoptosis.
Kim JY; Lim DM; Park HS; Moon CI; Choi KJ; Lee SK; Baik HW; Park KY; Kim BJ
J Pharmacol Sci; 2012; 118(1):65-74. PubMed ID: 22186619
[TBL] [Abstract][Full Text] [Related]
10. Causes and cures for endoplasmic reticulum stress in lipotoxic β-cell dysfunction.
Cnop M; Ladrière L; Igoillo-Esteve M; Moura RF; Cunha DA
Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():76-82. PubMed ID: 21029303
[TBL] [Abstract][Full Text] [Related]
11. Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes.
Laybutt DR; Preston AM; Akerfeldt MC; Kench JG; Busch AK; Biankin AV; Biden TJ
Diabetologia; 2007 Apr; 50(4):752-63. PubMed ID: 17268797
[TBL] [Abstract][Full Text] [Related]
12. Sustained production of spliced X-box binding protein 1 (XBP1) induces pancreatic beta cell dysfunction and apoptosis.
Allagnat F; Christulia F; Ortis F; Pirot P; Lortz S; Lenzen S; Eizirik DL; Cardozo AK
Diabetologia; 2010 Jun; 53(6):1120-30. PubMed ID: 20349222
[TBL] [Abstract][Full Text] [Related]
13. Enhanced protection against cytokine- and fatty acid-induced apoptosis in pancreatic beta cells by combined treatment with glucagon-like peptide-1 receptor agonists and insulin analogues.
Tews D; Werner U; Eckel J
Horm Metab Res; 2008 Mar; 40(3):172-80. PubMed ID: 18348079
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-Like Peptide 1 Protects Pancreatic β-Cells From Death by Increasing Autophagic Flux and Restoring Lysosomal Function.
Zummo FP; Cullen KS; Honkanen-Scott M; Shaw JAM; Lovat PE; Arden C
Diabetes; 2017 May; 66(5):1272-1285. PubMed ID: 28232493
[TBL] [Abstract][Full Text] [Related]
15. Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells.
Li Y; Tweedie D; Mattson MP; Holloway HW; Greig NH
J Neurochem; 2010 Jun; 113(6):1621-31. PubMed ID: 20374430
[TBL] [Abstract][Full Text] [Related]
16. The GLP-1 analog exendin-4 modulates HSP72 expression and ERK1/2 activity in BTC6 mouse pancreatic cells.
Madhu D; Khadir A; Hammad M; Kavalakatt S; Dehbi M; Al-Mulla F; Abubaker J; Tiss A
Biochim Biophys Acta Proteins Proteom; 2020 Jul; 1868(7):140426. PubMed ID: 32272193
[TBL] [Abstract][Full Text] [Related]
17. Chemical chaperone-conjugated exendin-4 as a cytoprotective agent for pancreatic β-cells.
Son S; Park EJ; Kim Y; Lee KC; Na DH
Int J Biochem Cell Biol; 2018 Dec; 105():13-19. PubMed ID: 30273669
[TBL] [Abstract][Full Text] [Related]
18. The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients.
Marchetti P; Bugliani M; Lupi R; Marselli L; Masini M; Boggi U; Filipponi F; Weir GC; Eizirik DL; Cnop M
Diabetologia; 2007 Dec; 50(12):2486-94. PubMed ID: 17906960
[TBL] [Abstract][Full Text] [Related]
19. Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis.
Fan R; Li X; Gu X; Chan JC; Xu G
Diabetes Obes Metab; 2010 Sep; 12(9):815-24. PubMed ID: 20649634
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Exposure of Pancreatic β-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response.
Natalicchio A; Biondi G; Marrano N; Labarbuta R; Tortosa F; Spagnuolo R; D'Oria R; Carchia E; Leonardini A; Cignarelli A; Perrini S; Laviola L; Giorgino F
Endocrinology; 2016 Jun; 157(6):2243-58. PubMed ID: 27035653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
